Volver al ranking

Thumbnails similares a Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD

20 vecinos (thumb_512) · 55 views · HCPLive · Estados Unidos

Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD

HCPLive

@hcplivenews

55Estados Unidos
13Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome

HCPLive

@hcplivenews

2.0KEstados Unidos64
19Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD

HCPLive

@hcplivenews

152Estados Unidos63
2GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD

HCPLive

@hcplivenews

151Estados Unidos69
4FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD

HCPLive

@hcplivenews

131Estados Unidos67
7FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD

HCPLive

@hcplivenews

123Estados Unidos66
11Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk

HCPLive

@hcplivenews

120Estados Unidos65
10Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes | ATS 2026

HCPLive

@hcplivenews

117Estados Unidos66
14Key Off-Label Treatment Options in Dermatology, With Matthew Zirwas, MD

HCPLive

@hcplivenews

117Estados Unidos64
20Lonvo-z at EAACI: Secondary Data & QoL Findings in HAE | Aleena Banerji, MD

HCPLive

@hcplivenews

91Estados Unidos63
6SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes

HCPLive

@hcplivenews

86Estados Unidos66
18GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy

HCPLive

@hcplivenews

80Estados Unidos63
9Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD

HCPLive

@hcplivenews

69Estados Unidos66
1Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD

HCPLive

@hcplivenews

68Estados Unidos76
5Improving Air Quality Indices for Personalized Health Warnings from Pollution Exposure

HCPLive

@hcplivenews

63Estados Unidos67
15SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026

HCPLive

@hcplivenews

48Estados Unidos64
17Lifestyle, Pharmacologic Therapies, and EXCEL Trial Data Reshape MASLD Treatment Framework

HCPLive

@hcplivenews

48Estados Unidos64
12What Factors Should Guide Atopic Dermatitis Treatment Selection? With Walter Liszewski, MD

HCPLive

@hcplivenews

46Estados Unidos64
8FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines

HCPLive

@hcplivenews

33Estados Unidos66
3Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD

HCPLive

@hcplivenews

21Estados Unidos67
16How ABCG2 Inhibition Could Change EPP Disease Management

HCPLive

@hcplivenews

17Estados Unidos64